Zobrazeno 1 - 10
of 36
pro vyhledávání: '"George K. Szabo"'
Autor:
Raymon Durso, Barbara A. Evans, Thomas R. Browne, Ephraim G. Josephs, H. H. Fernandez, George K. Szabo, James E. Evans
Publikováno v:
The Journal of Clinical Pharmacology. 40:854-860
Carbidopa (CD), a competitive inhibitor of aromatic l-amino acid decarboxylase that does not cross the blood-brain barrier, is routinely administered with levodopa (LD) to patients with Parkinson disease (PD) to reduce the peripheral decarboxylation
Publikováno v:
The Journal of Clinical Pharmacology. 33:246-252
Stable isotope labeling in therapeutic and subtherapeutic quantities of drug (15N2(13)C-phenobarbital) can be quantitated in biological matrices (urine) and high performance liquid chromatography (HPLC) peaks from urine using continuous-flow isotope-
Autor:
Gerald E. Schumacher, George K. Szabo, Thomas R. Browne, David J. Greenblatt, James E. Evans, Barbara A. Evans
Publikováno v:
The Journal of Clinical Pharmacology. 32:1141-1145
The authors show that for a drug cleared by one enzyme the area under the serum concentration-time curve from time 0 to infinity (AUC0-INF) of a test dose can be expressed as AUC0-INF = TD x F x (Km + C)/Vmax where TD is test dose size, F is fraction
Autor:
Thomas R. Browne, George K. Szabo, Wendy R. Galpern, Lawrence G. Miller, David J. Greenblatt, Richard I. Shader
Publikováno v:
Biochemical Pharmacology. 42:S99-S104
Clinical studies suggest that carbamazepine may attenuate effects of alprazolam discontinuation. Since discontinuation of chronic alprazolam in a mouse model is associated with behavioral alterations and upregulation at the gamma-aminobutyric acidA (
Publikováno v:
Journal of Chromatography A. 535:279-285
Accurate urinary measurements of the two major metabolites of phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin (p-HPPH) and 5-(3,4-dihydroxy-cyclohexa-1,5-dienyl)-5-phenylhydantoin (dihydrodiol, DHD), are necessary for pharmacokinetic and drug-intera
Autor:
Gerald E. Schumacher, Carol T. Walsh, Thomas R. Browne, James E. Evans, Barbara A. Evans, George K. Szabo
Publikováno v:
The Journal of Clinical Pharmacology. 30:578-584
We show that for drugs metabolized by one enzyme the slope of a plot of serum concentration (C) versus 1/clearance (CL) is linear with a value of 1/Vmax in the presence of substrate saturation and may be linear (rarely) or curved (usually) with a slo
Publikováno v:
The Journal of Clinical Pharmacology. 30:482-488
An equation is derived to estimate mean steady state serum concentration (Css) from trough steady state serum concentration (Cmin) which can be used for drugs with either linear or nonlinear pharmacokinetic properties. In 15 subjects receiving phenyt
Publikováno v:
Journal of clinical pharmacology. 38(4)
We propose performing human mass balance studies by administering stable isotope labeled ( 13 C or 15 N) drug and quantitating excess (above background) 13 C or 15 N in urine, serum, and feces by continuous flow-isotope ratio mass spectrometry (CF-IR
Autor:
Ephraim G. Josephs, Dana Jennings, George K. Szabo, Barbara A. Evans, James E. Evans, Raymon Durso, Thomas R. Browne, Joseph S. Handler
Publikováno v:
Annals of neurology. 42(3)
We report the use of a new stable isotope-labeled form of levodopa (LD) to examine in vivo central LD metabolism in Parkinson's disease (PD). Eight patients representing a wide spectrum of disease severity were administered 50 mg of carbidopa orally
Publisher Summary This chapter reviews the work to develop simple general methods for performing a mass balance/metabolite identification (MB/MI) study on any new drug using stable isotope labeling (SIL) and detection as an alternative to radioactive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26725ca522a848aa21f5de39a7f50e7c
https://doi.org/10.1016/s0165-7208(97)80158-4
https://doi.org/10.1016/s0165-7208(97)80158-4